Melanoma/Skin Cancer

Top Story

Cohort study finds 8% risk for secondary primary melanoma within 5 years

September 20, 2019
Feature

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular therapies for cancer…
Feature

AACR Cancer Progress Report: Past federal investments in NIH spurring breakthroughs in care

September 18, 2019
The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is paying dividends in…
In the Journals

Mohs surgery offers greater survival benefit vs. wide local excision in head and neck melanoma

September 9, 2019
Melanomas of the head and neck treated with Mohs micrographic surgery had a significantly higher overall survival at 5 years after melanoma diagnosis than those treated…
More Headlines »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Bristol-Myers Squibb.

For patients diagnosed with metastatic melanoma, the lifetime incidence of brain metastasis is more than 50% and is…
More »
Video
Meeting News

VIDEO: Cemiplimab ‘a new standard’ for metastatic cutaneous squamous cell carcinoma

June 15, 2019
More »
Resource Centers